<DOC>
	<DOCNO>NCT00467467</DOCNO>
	<brief_summary>To assess impact alfuzosin vs. placebo ureteral stent discomfort , urinary symptom quality life .</brief_summary>
	<brief_title>Alfuzosin Hydrochloride Relieve Ureteral Stent Discomfort</brief_title>
	<detailed_description />
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Age &gt; 18 Undergoing unilateral retrograde ureteroscopy ureteral stent placement Significant ureteral trauma Concomitant ESWL secondary surgical procedure may impact patient comfort Subject know hypersensitivity alfuzosin hydrochloride component alfuzosin hydrochloride tablet . Pregnancy , nurse mother , woman childbearing age unwilling take contraception duration study Undergoing bilateral ureteral stenting Undergoing antegrade ureteral stenting Undergoing simultaneous extracorporeal shockwave lithotripsy Urinary infection ( fever &gt; 101 , positive urine culture , many bacteria urinalysis ) Primary bladder dysfunction would impact ability void without catheter Neurologic dysfunction would impair pain sensation History chronic pain substance abuse Potent CYP3A4 inhibitor ketoconazole , itraconazole , ritonavir , since alfuzosin blood level increase Other alphablockers Phosphodiesterase type 5 inhibitor erectile function Any subject principal investigator feel would best interest participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>